Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
SESSION 10: UPDATES IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER
Current and Future Treatment Paradigms in 2nd Line Endometrial Cancer
Friday, April 29, 2022
3:10 PM – 3:30 PM
Speaker(s)
Joyce Liu, MD, MPH
Dana-Farber Cancer Institute
Boston, Massachusetts
Learning Objectives:
Describe the implications of evolving EC classification systems for clinical practice
Evaluate newer and emerging targeted agents and immunotherapies in EC
Implement strategies for optimal management of adverse events in EC
Address cultural, ethnic, and racial disparities related to risk factors, diagnosis, and treatment in EC.